Sunshine Biopharma (SBFM) Leases (2019 - 2025)
Sunshine Biopharma's Leases history spans 5 years, with the latest figure at $778846.0 for Q4 2025.
- For Q4 2025, Leases fell 16.79% year-over-year to $778846.0; the TTM value through Dec 2025 reached $778846.0, down 16.79%, while the annual FY2025 figure was $778846.0, 16.79% down from the prior year.
- Leases reached $778846.0 in Q4 2025 per SBFM's latest filing, down from $820489.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $936037.0 in Q4 2024 to a low of $541468.0 in Q3 2024.
- Average Leases over 4 years is $734260.5, with a median of $728129.0 recorded in 2023.
- Peak YoY movement for Leases: decreased 20.69% in 2024, then soared 58.32% in 2025.
- A 4-year view of Leases shows it stood at $760409.0 in 2022, then decreased by 14.94% to $646779.0 in 2023, then surged by 44.72% to $936037.0 in 2024, then decreased by 16.79% to $778846.0 in 2025.
- Per Business Quant, the three most recent readings for SBFM's Leases are $778846.0 (Q4 2025), $820489.0 (Q3 2025), and $892817.0 (Q2 2025).